Sunil Cutinho - CME President - CME Clearing

MX4A Stock  EUR 224.65  2.35  1.04%   

President

Mr. Sunil Cutinho is President of CME Clearing of the Company. Mr. Cutinho has served as President of CME Clearing since September 2014. He joined CME Group in 2002 and since then has held various positions of increasing responsibility within the organization and, most recently served as Managing Director, Deputy Head of CME Clearing from April 2014 through September 2014. since 2014.
Age 51
Tenure 10 years
Phone312 930 1000
Webhttps://www.cmegroup.com

CME Management Efficiency

The company has return on total asset (ROA) of 0.0101 % which means that it generated a profit of $0.0101 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0992 %, meaning that it generated $0.0992 on every $100 dollars invested by stockholders. CME's management efficiency ratios could be used to measure how well CME manages its routine affairs as well as how well it operates its assets and liabilities.
CME Group has accumulated 3.42 B in total debt with debt to equity ratio (D/E) of 15.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CME Group has a current ratio of 1.03, suggesting that it may not be capable to disburse its financial obligations in time and when they become due. Debt can assist CME until it has trouble settling it off, either with new capital or with free cash flow. So, CME's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CME Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CME to invest in growth at high rates of return. When we think about CME's use of debt, we should always consider it together with cash and equity.
CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME GROUP operates under Financial Exchanges classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4590 people. CME Group (MX4A) is traded on Frankfurt Exchange in Germany and employs 3,460 people.

Management Performance

CME Group Leadership Team

Elected by the shareholders, the CME's board of directors comprises two types of representatives: CME inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CME. The board's role is to monitor CME's management team and ensure that shareholders' interests are well served. CME's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CME's outside directors are responsible for providing unbiased perspectives on the board's policies.
Hilda Piell, Chief Human Resource Officer, Senior Managing Director
Terrence Duffy, Executive Chairman of the Board and Presidentident
Anita Liskey, Sr Communications
Jonathan Marcus, Sr Counsel
John Peschier, Managing Relations
Eileen Keeve, Managing Devel
Sunil Cutinho, President - CME Clearing
Jack Tobin, Chief Accounting Officer, Managing Director
Julie Holzrichter, Senior Managing Director - Global Operations

CME Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CME a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in CME Stock

When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.